Active

FOR PLUS PHARMA

Switched

BE0743663465

Rechtspersoon Private limited company

Espace Européen d'Entreprises 17, 6560 Erquelinnes Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren

Active for

6 year, 6 months

Financials

Financial year 2024

Gross margin

€ 19,543

▲ 162% vs 2023

Profit

Growing

€ 1,200

▲ 102% vs 2023

Debts

High

€ 230,713

▼ 3% vs 2023

FOR PLUS PHARMA from Erquelinnes, company number BE0743663465, closed financial year 2024 with a result of € 1,200 after tax. For that financial year FOR PLUS PHARMA recorded a gross margin of € 19,543 and equity of € 17,162. Compared with financial year 2023, the result moved from € -49,251 to € 1,200. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 19, 2025.

What happened at FOR PLUS PHARMA?

What happened at FOR PLUS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: profit of € 1,200. filed late Source: NBB ↗
  • STEPHANE CAMBRAYE became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 106,185 profit in 2020 to € 1,200 profit in 2024.

Paid € 45,732 in corporate taxes since 2020.

Best year ever: 2020, with € 106,185 profit.

A new publication or filing at FOR PLUS PHARMA? We notify you, reason included.

Follow FOR PLUS PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

STEPHANE CAMBRAYE
FOR PLUS PHARMA

Behind FOR PLUS PHARMA is STEPHANE CAMBRAYE. It owns 13% of LOCAL INVEST GROUP itself.

See the full network in the app

Directors

According to the 2024 annual accounts

STEPHANE CAMBRAYE

Director

Also active at: DM GS

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Espace Européen d'Entreprises 17 box B

6560 Erquelinnes

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0743.663.465
VAT number
BE 0743.663.465
Registered office
Espace Européen d'Entreprises 17 bus B, 6560 Erquelinnes
Names & denominations
FOR PLUS PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
14 February 2020
Peppol
Active · Active since 19 Feb 2026
Activities · NACE

Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren

Overige niet-gespecialiseerde detailhandel

Detailhandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Detailhandel via postorderbedrijven of via internet

Frequently asked questions

What is the enterprise number of FOR PLUS PHARMA?
The enterprise number of FOR PLUS PHARMA is BE0743663465.
What is the address of FOR PLUS PHARMA?
The registered office of FOR PLUS PHARMA is located at Espace Européen d'Entreprises 17 box B, 6560 Erquelinnes.
When was FOR PLUS PHARMA founded?
FOR PLUS PHARMA was founded on 14 February 2020.
What is the main activity of FOR PLUS PHARMA?
The main activity of FOR PLUS PHARMA is "Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren" (NACE code 46150).
Does FOR PLUS PHARMA have a website?
No website is currently known for FOR PLUS PHARMA.
How much profit did FOR PLUS PHARMA make in 2024?
FOR PLUS PHARMA posted a profit after taxes of € 1,200 in financial year 2024.
What is the revenue of FOR PLUS PHARMA?
As a small company, FOR PLUS PHARMA is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 19,543.
Where can I find the annual accounts of FOR PLUS PHARMA?
FOR PLUS PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of FOR PLUS PHARMA?
According to the 2024 annual accounts, the directors of FOR PLUS PHARMA are: STEPHANE CAMBRAYE.
Who owns FOR PLUS PHARMA?
Behind FOR PLUS PHARMA is STEPHANE CAMBRAYE. It owns 13% of LOCAL INVEST GROUP itself.